Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 313 (5787): 627-628

Copyright © 2006 by the American Association for the Advancement of Science

IMMUNOLOGY:
Enhanced: Sugar Determines Antibody Activity

Dennis R. Burton1 and Raymond A. Dwek2

Understanding the functional consequences of the identity and sequence of the sugars attached to antibodies may be useful in designing therapies for a range of disorders.


1D. R. Burton is in the Departments of Immunology and Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. E-mail: burton{at}scripps.edu

2R. A. Dwek is at the Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK. E-mail: raymond.dwek{at}exeter.ox.ac.uk


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for Fc{gamma}R2a and Fc{gamma}R2b.
M. E. Ackerman, A.-S. Dugast, E. G. McAndrew, S. Tsoukas, A. F. Licht, D. J. Irvine, and G. Alter (2013)
J. Virol. 87, 5468-5476
   Abstract »    Full Text »    PDF »
IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis.
L. N. TROELSEN, S. JACOBSEN, J. L. ABRAHAMS, L. ROYLE, P. M. RUDD, E. NARVESTAD, N. H. HEEGAARD, and P. GARRED (2012)
J Rheumatol 39, 463-469
   Abstract »    Full Text »    PDF »
Identification and Quantification of Glycoproteins Using Ion-Pairing Normal-phase Liquid Chromatography and Mass Spectrometry.
W. Ding, H. Nothaft, C. M. Szymanski, and J. Kelly (2009)
Mol. Cell. Proteomics 8, 2170-2185
   Abstract »    Full Text »    PDF »
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.
S. A. Beers, C. H. T. Chan, S. James, R. R. French, K. E. Attfield, C. M. Brennan, A. Ahuja, M. J. Shlomchik, M. S. Cragg, and M. J. Glennie (2008)
Blood 112, 4170-4177
   Abstract »    Full Text »    PDF »
Sweet and sour: the impact of sugars on disease.
A. Alavi and J. S. Axford (2008)
Rheumatology 47, 760-770
   Abstract »    Full Text »    PDF »
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
M. Collin, O. Shannon, and L. Bjorck (2008)
PNAS 105, 4265-4270
   Abstract »    Full Text »    PDF »
A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits.
C. Jin, F. Altmann, R. Strasser, L. Mach, M. Schahs, R. Kunert, T. Rademacher, J. Glossl, and H. Steinkellner (2008)
Glycobiology 18, 235-241
   Abstract »    Full Text »    PDF »
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects.
S. E. Strome, E. A. Sausville, and D. Mann (2007)
Oncologist 12, 1084-1095
   Abstract »    Full Text »    PDF »
Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?.
J. D. Dimitrov, J. Bayry, S. Siberil, and S. V. Kaveri (2007)
Nephrol. Dial. Transplant. 22, 1301-1304
   Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882